Impaired hemostasis. |
Von Willebrand’s disease and other primary disorders of clotting exacerbate normal menstrual bleeding. |
Impaired hemostasis with some derangement in blood vessels. |
Anovulatory bleeding – absence of progesterone effects results in reduced endometrial stromal cell tissue factor and plasminogen activator inhibitor-1 production, increased matrix metalloproteinase activity and increased angiogenic factor expression. This creates vascular instability with greatly impaired hemostasis, each predisposing to break-through bleeding. |
Aberrant blood vessels with normal hemostasis. |
Long-term, progestin-only contraceptives reduce endometrial blood flow, and the resultant hypoxia and reactive oxygen species drive expression of angiogenic factors and perivascular MMP-2 production. This creates large, fragile, easily fractured superficial endometrial blood vessels held in place by a collapsing stromal extracellular matrix that promotes intermittent bleeding. |
Aberrant blood vessels with normal hemostasis. |
Myomas – are associated with long-standing increased angiogenesis and an increasingly estrogenic milieu which leads to dilated veins (venule ectasia) and increased arterial flow promoting menorrhagia. |
Aberrant blood vessels with normal hemostasis. |
Polyps – are associated with increased angiogenesis and focal vascular abnormalities leading to metorrhagia. |